SEC filings and other documents

Q2 revenue surged on Novera sales, with robust cash, key partnerships, and a $100M U.S. LOI.

Pioneering scalable superconducting quantum systems, targeting 1,000+ qubits at high fidelity.

Director election and auditor ratification approved; no shareholder questions submitted.

Quantum breakthroughs and major funding accelerate commercialization, with modular architectures leading.

Chiplet-based quantum systems drive rapid scaling and industry adoption, with strong global investment.

Q1 revenue more than doubled as the 108-qubit system launched and customer adoption accelerated.

Pioneering scalable superconducting quantum systems, targeting 1,000+ qubits and industry leadership.

Aiming for 1,000 qubits and quantum advantage in three years, with strong funding and partnerships.

Targets 1,000+ qubits at 99.9% fidelity by 2029, leveraging proprietary chiplet technology.

Record gate fidelities, strong cash position, and major orders drive roadmap to quantum advantage.

Revenue fell, but new contracts and strong cash support ambitious quantum roadmap to 2029.

Released Cepheus-1-36Q, advanced roadmap, and strengthened cash position despite lower Q2 revenue.

Industry-leading multi-chip quantum systems and strategic partnerships drive rapid progress.

Directors were elected and the auditor ratified, with all proposals approved by shareholders.

Revenue down, net income up on non-cash gain; major R&D and strategic milestones achieved.

Superconducting quantum computing advances with high fidelity, modular scaling, and strong industry partnerships.

Superconducting quantum computing advances with chiplet scalability, high fidelity, and strong funding.

2024 saw Rigetti's revenue fall, losses widen, and major equity and technical milestones achieved.